Pages that link to "Q30418998"
Jump to navigation
Jump to search
The following pages link to Protection by a recombinant Mycobacterium bovis Bacillus Calmette-Guerin vaccine expressing Shiga toxin 2 B subunit against Shiga toxin-producing Escherichia coli in mice. (Q30418998):
Displaying 9 items.
- Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy (Q26798372) (← links)
- Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection (Q27026551) (← links)
- Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype (Q28087714) (← links)
- Recent advances in understanding enteric pathogenic Escherichia coli. (Q34375210) (← links)
- Stable Expression of Lentiviral Antigens by Quality-Controlled Recombinant Mycobacterium bovis BCG Vectors (Q35773904) (← links)
- Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni. (Q35887055) (← links)
- Comparative genomics and immunoinformatics approach for the identification of vaccine candidates for enterohemorrhagic Escherichia coli O157:H7. (Q37713379) (← links)
- Role for Gr-1+ cells in the control of high-dose Mycobacterium bovis recombinant BCG. (Q42213007) (← links)
- Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development. (Q53696162) (← links)